Cargando…

Insulins for the long term management of diabetes mellitus in dogs: a review

The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiel, Robert E., Mooney, Carmel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842735/
https://www.ncbi.nlm.nih.gov/pubmed/35152907
http://dx.doi.org/10.1186/s40575-022-00114-9
_version_ 1784651111737589760
author Shiel, Robert E.
Mooney, Carmel T.
author_facet Shiel, Robert E.
Mooney, Carmel T.
author_sort Shiel, Robert E.
collection PubMed
description The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined to die from their diabetes mellitus returned to life. Over the past 100 years, insulin formulations have been modified to attempt to provide a predictable and prolonged duration of action while avoiding the development of hypoglycaemia. This has led to an ever-growing variety of insulin types in human medicine, many of which have subsequently been used in dogs. The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus.
format Online
Article
Text
id pubmed-8842735
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88427352022-02-16 Insulins for the long term management of diabetes mellitus in dogs: a review Shiel, Robert E. Mooney, Carmel T. Canine Med Genet Review The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined to die from their diabetes mellitus returned to life. Over the past 100 years, insulin formulations have been modified to attempt to provide a predictable and prolonged duration of action while avoiding the development of hypoglycaemia. This has led to an ever-growing variety of insulin types in human medicine, many of which have subsequently been used in dogs. The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus. BioMed Central 2022-02-14 /pmc/articles/PMC8842735/ /pubmed/35152907 http://dx.doi.org/10.1186/s40575-022-00114-9 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Shiel, Robert E.
Mooney, Carmel T.
Insulins for the long term management of diabetes mellitus in dogs: a review
title Insulins for the long term management of diabetes mellitus in dogs: a review
title_full Insulins for the long term management of diabetes mellitus in dogs: a review
title_fullStr Insulins for the long term management of diabetes mellitus in dogs: a review
title_full_unstemmed Insulins for the long term management of diabetes mellitus in dogs: a review
title_short Insulins for the long term management of diabetes mellitus in dogs: a review
title_sort insulins for the long term management of diabetes mellitus in dogs: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842735/
https://www.ncbi.nlm.nih.gov/pubmed/35152907
http://dx.doi.org/10.1186/s40575-022-00114-9
work_keys_str_mv AT shielroberte insulinsforthelongtermmanagementofdiabetesmellitusindogsareview
AT mooneycarmelt insulinsforthelongtermmanagementofdiabetesmellitusindogsareview